Finance

Lists
Why is PI6 up 2.83%?
Dive Deeper
PI6:FRA
Palvella Therapeutics Inc
€109.00
+2.83%
(+3.00) 1D
Oct 20, 8:04:55 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PI6...
Open
€109.00
High
€109.00
Low
€109.00
Mkt. cap
1.81B
Avg. vol.
12.00
Volume
0.00
52-wk high
€137.00
52-wk low
€60.00
No. of employees
29
Open
€109.00
High
€109.00
Low
€109.00
Mkt. cap
1.81B
Avg. vol.
12.00
Volume
0.00
52-wk high
€137.00
52-wk low
€60.00
No. of employees
29
News stories
From web sources and news partners
About Palvella Therapeutics Inc
CEO-
Employees29
Founded-
Headquarters-
SectorBiotechnology
Websitepalvellatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.53M
7.12M
9.33M
12.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.65M
4.18M
5.52M
8.93M
Operating expense
10.18M
11.30M
14.86M
21.40M
Total operating expenses
10.18M
11.30M
14.86M
21.40M
Operating income
-10.18M
-11.30M
-14.86M
-21.40M
Other non operating income
-286.00K
-191.00K
54.00K
-122.00K
EBT including unusual items
-11.34M
-12.71M
-15.77M
-21.87M
EBT excluding unusual items
-11.34M
-12.71M
-15.77M
-21.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.34M
-12.71M
-15.77M
-21.87M
Net profit margin
-
-
-
-
Earnings per share
-1.03
-1.08
-1.20
-1.52
Interest and investment income
628.00K
520.00K
1.07M
1.96M
Interest expense
-1.51M
-1.74M
-2.04M
-2.31M
Net interest expenses
-882.00K
-1.22M
-966.00K
-343.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps